For biotech companies planning an IPO, navigating market dynamics, investor expectations, and regulatory hurdles is critical to success. This session brings together industry leaders to share insights on the evolving biotech IPO landscape, including current trends, valuation strategies, and capital market conditions. Panelists will discuss key factors in preparing for a public debut—optimal timing, market positioning, and crafting a compelling investor narrative. Drawing from recent IPO experiences, speakers will highlight common challenges, strategic considerations, and best practices for a smooth transition to the public markets. Whether attendees are in early planning stages or gearing up for an offering, this discussion will provide actionable insights to maximize IPO success.

Wilson Sonsini partner Jennifer Fang will serve as a panelist on this exciting topic.